Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Natural antitumor substances with broad-spectrum activity isolated by Banyu scientists

May 5, 1998

Dainippon discloses pyridines for CNS disorders

May 5, 1998

Taisho prepares new cytokine inhibitors for inflammatory, allergic and other disorders

May 5, 1998

Sumitomo claims beta-lactams active against resistant staphylococci

May 5, 1998

Takeda developing carbapenems for Gram-negative infections

May 5, 1998

Antitumor agents of microbial origin discovered by Nippon Kayaku

May 5, 1998

Novel iNOS inhibitors developed by Nippon Kayaku

May 4, 1998

Bayer's potassium channel ligands for cognition disorders

May 4, 1998

Pfizer synthesizes dual ORL1 antagonists/opioid receptor agonists

May 4, 1998

Lymphocyte-stimulating factor and methods of treating or preventing African sleeping sickness

May 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...